Literature DB >> 16240237

Saccharomyces boulardii inhibits water and electrolytes changes induced by castor oil in the rat colon.

Philippe Girard1, Yannick Pansart, Marie-Claude Coppe, Jean-Marie Gillardin.   

Abstract

The biotherapeutic agent Saccharomyces boulardii has been shown to inhibit castor oil-induced diarrhoea in rats. The present study investigated the mechanism(s) of this antidiarrhoeal effect in terms of water and electrolyte (sodium, potassium and chloride) changes using two rat models. A single oral dose of S. boulardii of up to 12 x 10(10) CFU/kg of viable cells did not inhibit castor oil-induced fluid secretion in the enteropooling model. However, the yeast dose dependently reduced castor oil induced fluid secretion into the colon, with a significant protection at 12 x 10(10) CFU/kg. In this model, castor oil reversed net sodium and chloride absorption into net secretion, and increased net potassium secretion into the lumen. Single pre-treatment with S. boulardii at 4 and 12 x 10(10) CFU/kg dose dependently decreased these electrolyte changes. In conclusion, S. boulardii possesses potent anti-secretory properties versus water and electrolyte secretion induced by castor oil in the rat colon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240237     DOI: 10.1007/s10620-005-3029-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Ricinoleic acid: current view of an ancient oil.

Authors:  T S Gaginella; S F Phillips
Journal:  Am J Dig Dis       Date:  1975-12

2.  Enteropooling assay: a test for diarrhea produced by prostaglandins.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar; M S Klepper
Journal:  Prostaglandins       Date:  1976-05

3.  Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon.

Authors:  E Beubler; H Juan
Journal:  J Pharm Pharmacol       Date:  1979-10       Impact factor: 3.765

4.  Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon.

Authors:  H Tamai; T S Gaginella
Journal:  Free Radic Res Commun       Date:  1993

5.  [Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].

Authors:  H Kollaritsch; H Holst; P Grobara; G Wiedermann
Journal:  Fortschr Med       Date:  1993-03-30

6.  Nitric oxide synthase induction and intestinal epithelial cell viability in rats.

Authors:  B L Tepperman; J F Brown; B J Whittle
Journal:  Am J Physiol       Date:  1993-08

7.  Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea--a pilot study.

Authors:  K Plein; J Hotz
Journal:  Z Gastroenterol       Date:  1993-02       Impact factor: 2.000

8.  Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.

Authors:  Philippe Girard; Yannick Pansart; Ingrid Lorette; Jean-Marie Gillardin
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

9.  Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

Authors:  J P Buts; G Corthier; M Delmee
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-05       Impact factor: 2.839

10.  Nitric oxide involvement in sodium choleate-induced fluid secretion and diarrhoea in rats.

Authors:  N Mascolo; T S Gaginella; A A Izzo; G Di Carlo; F Capasso
Journal:  Eur J Pharmacol       Date:  1994-10-13       Impact factor: 4.432

View more
  7 in total

1.  Increased intestinal delivery of viable Saccharomyces boulardii by encapsulation in microspheres.

Authors:  Sandrine Graff; Sajjad Hussain; Jean-Claude Chaumeil; Christine Charrueau
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

2.  Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation.

Authors:  S Thomas; I Przesdzing; D Metzke; J Schmitz; A Radbruch; D C Baumgart
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

3.  Saccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation state.

Authors:  Alexandra Canonici; Emilie Pellegrino; Carole Siret; Chloé Terciolo; Dorota Czerucka; Sonia Bastonero; Jacques Marvaldi; Dominique Lombardo; Véronique Rigot; Frédéric André
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

4.  Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptor.

Authors:  Alexandra Canonici; Carole Siret; Emilie Pellegrino; Rodolphe Pontier-Bres; Laurent Pouyet; Marie Pierre Montero; Carole Colin; Dorota Czerucka; Véronique Rigot; Frédéric André
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 5.  Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review.

Authors:  Margret I Moré; Alexander Swidsinski
Journal:  Clin Exp Gastroenterol       Date:  2015-08-14

6.  Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx.

Authors:  Yong Zhang; Xiao Guo; Jianlin Guo; Qiuwen He; He Li; Yuqin Song; Heping Zhang
Journal:  Sci Rep       Date:  2014-07-18       Impact factor: 4.379

7.  Antidiarrheal Action of Bacillus subtilis CU1 CNCM I-2745 and Lactobacillus plantarum CNCM I-4547 in Mice.

Authors:  Maria C Urdaci; Marie Lefevre; Guylene Lafforgue; Christel Cartier; Bertrand Rodriguez; Jean Fioramonti
Journal:  Front Microbiol       Date:  2018-07-10       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.